Gene set that shows which patients benefit from chemo after surgery identified

Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ("adjuvant chemotherapy").

Read the whole article on Science Daily

More from Science Daily